Stryker Q3 FY24: where the revenue came from and where it went
The whole income statement of Stryker for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jul 1 – Sep 30, 2024
- Reported
- Oct 30, 2024
Revenue$5.49B
+12% year over year
Gross profit$3.52B
64% margin
Operating profit$1.09B
20% margin
Net profit$0.83B
15% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 5.49 | 100% | +12% |
| Med surg & neurotechnology | 3.22 | 59% | +13% |
| Orthopaedics & spine | 2.27 | 41% | +11% |
| Cost of revenue | −1.98 | 36% | |
| Gross profit | 3.52 | 64% margin | +0pp |
| R&D | −0.38 | 7% | +0pp |
| SG&A | −1.89 | 34% | +0pp |
| Other | −0.16 | 3% | +0pp |
| Operating profit | 1.09 | 20% margin | +1pp |
| Interest & other costs | −0.04 | ||
| Tax | −0.21 | ||
| Net profit | 0.83 | 15% margin | +1pp |
209 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest